We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+9.02%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.27B
AUM Growth
+$957K
Cap. Flow
-$81.4M
Cap. Flow %
-6.43%
Top 10 Hldgs %
5.55%
Holding
1,966
New
431
Increased
565
Reduced
590
Closed
359

Top Buys

Rank Stock Value
1
CME icon
CME Group
CME
+$7.23M
2
LNKD
LinkedIn Corporation
LNKD
+$7.08M
3
PFE icon
Pfizer
PFE
+$6.7M
4
BBY icon
Best Buy
BBY
+$6.21M
5
PCYC
PHARMACYCLICS INC
PCYC
+$6.09M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$12.3M
2
HPQ icon
HP
HPQ
+$8.76M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$8.48M
4
BAX icon
Baxter International
BAX
+$6.78M
5
MPC icon
Marathon Petroleum
MPC
+$6.75M

Sector Composition

Rank Sector Weight
1 Industrials 12.7%
2 Healthcare 12.7%
3 Consumer Discretionary 11.82%
4 Technology 11.74%
5 Financials 10.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBI icon
1301
Designer Brands
DBI
$336M
$263K 0.02%
+6,144
New +$266K
MX icon
1302
Magnachip Semiconductor
MX
$134M
$263K 0.02%
13,472
-11,900
-47% -$240K
ICUI icon
1303
ICU Medical
ICUI
$4.3B
$262K 0.02%
+4,120
New +$265K
JPM icon
1304
JPMorgan Chase
JPM
$950B
$262K 0.02%
4,488
-42,148
-90% -$2.31M
WFC icon
1305
Wells Fargo
WFC
$267B
$262K 0.02%
5,762
-67,933
-92% -$2.93M
CPE
1306
DELISTED
Callon Petroleum Company
CPE
$262K 0.02%
4,012
-1,503
-27% -$96.1K
AGX icon
1307
Argan
AGX
$8.66B
$261K 0.02%
+9,456
New +$221K
LSAK icon
1308
Lesaka Technologies
LSAK
$415M
$261K 0.02%
+29,923
New +$318K
STZ icon
1309
Constellation Brands
STZ
$22.4B
$261K 0.02%
3,707
-3,805
-51% -$254K
TEX icon
1310
Terex
TEX
$7.55B
$261K 0.02%
+6,206
New +$225K
OMN
1311
DELISTED
OMNOVA Solutions Inc.
OMN
$261K 0.02%
28,691
-2,093
-7% -$18K
HZNP
1312
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$261K 0.02%
+34,200
New +$184K
AVG
1313
DELISTED
AVG Technologies N.V.
AVG
$260K 0.02%
15,102
-10,356
-41% -$201K
CSH
1314
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
$260K 0.02%
14,972
-19,291
-56% -$347K
AL
1315
DELISTED
Air Lease Corp
AL
$259K 0.02%
+8,348
New +$255K
LXU icon
1316
LSB Industries
LXU
$706M
$259K 0.02%
8,203
-9,153
-53% -$237K
VOD icon
1317
Vodafone
VOD
$36.3B
$259K 0.02%
+6,453
New +$243K
YUM icon
1318
Yum! Brands
YUM
$40.3B
$259K 0.02%
4,771
-31,288
-87% -$1.61M
ILG
1319
DELISTED
ILG, Inc Common Stock
ILG
$259K 0.02%
8,375
-1,199
-13% -$31.5K
DMC
1320
Del Monte Corp
DMC
$1.41B
$258K 0.02%
9,125
-1,290
-12% -$36.3K
MDU icon
1321
MDU Resources
MDU
$4.2B
$258K 0.02%
+22,228
New +$250K
SNBR
1322
DELISTED
Sleep Number
SNBR
$258K 0.02%
12,246
-11,938
-49% -$250K
DDD icon
1323
3D Systems Corp
DDD
$581M
$257K 0.02%
2,768
-10,691
-79% -$750K
NYT icon
1324
New York Times
NYT
$12.2B
$257K 0.02%
+16,214
New +$221K
TCOM icon
1325
Trip.com Group
TCOM
$29.5B
$257K 0.02%
+10,374
New +$271K
51 52
53
54 55

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q4 2013 Portfolio in Review

As of Q4 2013, GSA Capital Partners held 1,966 positions worth $1.27B, up 0.08% from $1.26B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

GSA Capital Partners withdrew a net $81.4M in Q4 2013, closing 359 positions and reducing 590 holdings. Its most notable exit was CVS Health, an estimated $12.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 13% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, GSA Capital Partners opened a new position in Pfizer worth $6.69M.

  • GSA Capital Partners's largest Q4 2013 buy was Pfizer: 230,320 shares worth $6.69M.
  • GSA Capital Partners added most to CME Group in Q4 2013, an estimated $7.23M increase.
  • GSA Capital Partners's biggest Q4 2013 reduction was HP, cutting an estimated $8.76M.
  • GSA Capital Partners fully exited CVS Health in Q4 2013, selling an estimated $12.3M.
  • GSA Capital Partners's ten largest holdings make up 5.6% of its $1.27B portfolio in Q4 2013.
  • GSA Capital Partners opened 431 new positions and closed 359 in Q4 2013.
  • GSA Capital Partners's portfolio value rose 0.08% quarter-over-quarter to $1.27B.

Based on GSA Capital Partners's 13F filing for Q4 2013, filed 12 Feb 2014.